Skip to content
Thursday, February 9, 2023
Latest:
  • Fusion Pharmaceuticals Appoints Donald Bergstrom, M.D., Ph.D., to Board of Directors
  • SQI Diagnostics Submits RALI-Dx(TM) IL-6 Severity Triage Test for COVID-19 Patients to FDA for Emergency Use Authorization
  • MindMed Announces 2020 Year-End Financial Results; Current Cash Balance of $161 million USD ($203 million CAD) to Support Drug Development Pipeline and Creation of Psychedelic Medicine Tech Platform
  • Xinhua Silk Road: Nanjing Jiangbei New Area invites global partners to jointly promote dev. of life and health industry
  • Amgen announces Artificial Intelligence (AI) Partnership with Mila
Biotech Stock Market Report

Biotech Stock Market Report

Know First, Act First

  • Covid-19
  • General
  • Financing
  • Pharma
  • Global
  • Trending

Trending

BIOTCHNO Trending 

Amgen announces Artificial Intelligence (AI) Partnership with Mila

March 16, 2021July 19, 2021 Raza

Canada NewsWire MONTREAL , March 16, 2021 /CNW/ – Amgen announced today that it has entered into a multi-year partnership

Read more
BIOTCHNO Trending 

FACIT Crowns 2021 Winner of Falcons’ Fortunes Pitch Competition; Announces Follow-on Investment in 2020 Winner, Bridge7 Oncology

February 4, 2021April 16, 2021 Desiree Justice

Canada NewsWire Showcasing Ontario’s emerging biotech entrepreneurs and driving value from intellectual propertyTORONTO,Feb. 4, 2021/CNW/ – FACIT, a commercialization venture

Read more
BIOTCHNO Trending 

The American FDA Awards The Cetylated Esters Patented By PharmaNutra Gras Substance Recognition

December 23, 2020April 16, 2021 vanessa

Canada NewsWire PISA, Italy,Dec. 23, 2020/CNW/ —PharmaNutra S.p.A.(the “Company“), specialised in iron-based nutritional supplements and in medical devices for muscles

Read more
BIOTCHNO Trending 

Health Canada Approves VENCLEXTA® (venetoclax) in combination with azacitidine or low dose cytarabine for untreated Acute Myeloid Leukemia (AML)

December 15, 2020May 24, 2021 vanessa

/* Style Definitions */ span.prnews_span { font-size:8pt; font-family:”Arial”; color:black; } a.prnews_a { color:blue; } li.prnews_li { font-size:8pt; font-family:”Arial”; color:black; }

Read more
BIOTCHNO Trending 

AbbVie and Eisai Announce an approval for additional indication of HUMIRA

November 27, 2020May 24, 2021 vanessa

AbbVie and Eisai Announce an approval for additional indication of HUMIRA TOKYO, Nov 27, 2020 – (JCN Newswire) – AbbVie

Read more

Covid-19

ImmunoPrecise and LiteVax Advance SARS-CoV-2 Vaccine Candidate
BIOTCHNO Covid-19 

ImmunoPrecise and LiteVax Advance SARS-CoV-2 Vaccine Candidate

December 14, 2020April 16, 2021 vanessa

VICTORIA, BC,Dec. 14, 2020/CNW/ – IMMUNOPRECISE ANTIBODIES LTD. (“IPA”) (TSXV: IPA) (IPATD: IPA) (FSE: TQB), a leader in full-service, therapeutic antibody

LuminUltra Expands Testing Capacity Including Range of COVID-19 Offerings with Acquisition of Source Molecular Corporation
BIOTCHNO Covid-19 

LuminUltra Expands Testing Capacity Including Range of COVID-19 Offerings with Acquisition of Source Molecular Corporation

November 30, 2020April 16, 2021 vanessa
Aerovirus Technologies Inc. (AvT) of St-Hyacinthe is developing the first real-time virus detection device, Aerovirus-1, to fight COVID-19.
BIOTCHNO Covid-19 

Aerovirus Technologies Inc. (AvT) of St-Hyacinthe is developing the first real-time virus detection device, Aerovirus-1, to fight COVID-19.

November 26, 2020April 16, 2021 vanessa
  • Disclaimer
  • Privacy Policy
TD Media LLC dba Life Water Media
1415 South Voss Road Suite 110-431 Houston, TX 77057